Stephen Pickett,
Manger,
GlaxoSmithKline
Dr Stephen Pickett has a degree in Chemistry from Oxford Univeristy and a Ph.D. from Imperial College/Royal Institution of Great Britain. Post-doctoral studies were undertaken at the Imperial Cancer Research Fund (now part of Cancer Research UK). He has nearly twenty years experience working within the pharmaceutical industry and currently leads a group at GlaxoSmithKline that provides computational chemistry and chemoinformatics support to medicinal chemistry and fragment based drug discovery projects, screening collection design and HTS data analysis. Dr. Pickett is the author of over 30 peer-reviewed scientific articles and reviews and is a named contributor on six patent applications.
|
|
|